Russian vaccine team in talks with China on combination trial
(Feb 5): Fresh off global validation of their Covid-19 vaccine’s extraordinary effectiveness, Russian developers are in talks with China’s CanSino Biologics Inc. to test a combined regimen of their shots to better protect against new virus strains, according to people with knowledge of the matter.
The Russian Direct Investment Fund, a partner in the Sputnik V vaccine program, forged a preliminary agreement with the Tianjin-based vaccine developer and Petrovax Pharm Llc, owned by billionaire Vladimir Potanin, to conduct tests in Russia, four people said, declining to be identified as the information isn’t public. Petrovax is Cansino’s Russian partner.
They are negotiating the design of the trial which would replace Sputnik’s second shot with CanSino’s, and may announce a plan as soon as this month, they said. Spokespeople for Petrovax and RDIF declined to comment, as did CanSino.
Researchers are looking at whether combining different developers’ vaccines in a two-shot regimen produces results that are as good as, or better than, using the same product as a booster. That flexibility could help to relieve pressure on individual vaccine makers if they run into manufacturing difficulties. While the Sputnik V program already has success using different vectors for its two doses, it has faced challenges ramping up production amid an ambitious rollout.
The prospect of a Russia-China tie-up could potentially offer developing countries a new tool to fight the pandemic and increase the two giants’ geopolitical influence as major western countries remain pre-occupied with their own crises.
Other tie-up plans are also progressing: the University of Oxford plans to start a trial combining vaccines from AstraZeneca Plc and Pfizer Inc., while Russia will begin testing a mix of Sputnik V with the AstraZeneca vaccine in the United Arab Emirates and Azerbaijan next week.
What I find interesting is this: "They are negotiating the design of the trial which would replace Sputnik’s second shot with CanSino’s, and may announce a plan as soon as this month, they said".
Could Solution's latest agreement with the MoH pave way for larger orders in future if the trial is proven to be successful? Interesting stuff given that the MoH had placed orders for both Sputnik V & Cansino's vaccine...
Quote: Covid-19 Vaccines distributed by Governments not directly to any clinics or hospitals. It is very important and tell all your family members and friends NOT TO BUY ANY vaccines from unofficial channels. Never buy smuggled vaccines from any source as only governments can receive and dispatch vaccines now, All Covid-19 Vaccines manufacturers only deliver to Governments. DO NOT fall into vaccines scam. Unquote
Director sold shares again and resigned at the same time. Must be too happy become instant millionaires sold 2mil shares total in 2 mths. Cost 20sen converted from warrant. Sold with over rm3mil in value. No wonder say busy with work commitment. Resigned lah. Correct?
Katak yesterday so action went to kanger asked me to come here sharing. after sharing shares turun. Apa lah. Dapat vaksin saham turun kah. Sell on news kahm Correct?
still dare to claim yrself judi guru, tak tau malu kah? u know what is malu kah? open so many ID to judi at different penny stocks and end up losing like shit, what a joke now still want to act like a guru and give lesson to others kah? u just a piece of shit, we throw it into jamban and flush away, that shud be yr destiny, right?
SGB caught my attention last August when they entered into a MOU with CanSino Bio to develop, manufacture and commercialize the CanSino Covic-19 vaccine here. Besides Covic-19 vaccine, their new F&F facility will also be able to accommodate the F&F process of the other types of vaccines, such as vaccine for meningococcal and pneumococcal.
Interestingly, PH Government had allocated RM60 million in Budget 2020 for pneumococcal vaccination. All children born on or after January 1, 2020, are eligible for the pneumococcal conjugate vaccine (PCV). The free pneumococcal vaccination under the National Immunisation Programme will benefit 500,000 children each year.
As for the meningococcal vaccine, Saudi health officials has made it mandatory for every pilgrim to be inoculated against the meningociccal disease, since the 2002 Hajj meningococcal outbreaks.
Forget about venturing into glove making or face masks, biotechnology (medical, agricultural and industrial) is going to play a big role in the survival of our species.
SGB has made the right decision to diversify into a relatively new field with great potential.
DISCLAIMER: This is not a BUY call but for sharing purposes only.
If you are looking to make money next week and next month I recommend to take a look at Esceram. The guys at Serba Dinamik like Dato Karim and friends are buying huge amount of Esceram share since last week. It potentially could be the next KPower and SCIB. Dont miss the boat
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Business101
644 posts
Posted by Business101 > 2021-02-05 15:27 | Report Abuse
Wehcant, you can't buy your ticket is it.?